Tcc denied for failing step therapy by Humana?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for tcc are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Tcc
## Why Humana Applies Step Therapy to Total Contact Casting — and How to Appeal
Humana's wound-care coverage policy requires documentation that less-intensive offloading modalities have been tried before approving total contact casting (TCC). This step-therapy requirement typically mandates evidence that the patient has been managed with removable offloading devices (removable cast walkers, surgical shoes, or prefabricated walkers) and that those modalities failed to heal the wound or were clinically inadequate. The denial is issued when that prior-failure documentation is absent from the submitted record, or when the reviewing clinician determines the step has not been completed.
## Why This Denial Is Appealable
Step-therapy requirements can be overridden in two ways. First, if the patient actually did undergo prior removable offloading and failed — and the chart documents it — the denial is based on an incomplete record review and the missing documentation can be provided on appeal. Second, if the treating clinician determined that removable offloading was clinically contraindicated or inadequate for this patient from the outset (e.g., a wound of a severity or depth where the treating provider elected to begin with TCC, or where the patient's documented adherence history made removable devices inappropriate), the step-therapy requirement can be waived on medical-necessity grounds. Many state laws and ACA regulations permit step-therapy exceptions when a prior-step drug or modality is clinically contraindicated or has previously failed.
## Federal Appeal Framework
- Internal appeal: File within 180 days. Include a step-therapy exception request citing the clinical basis for bypassing the prior step.
- Expedited appeal: If the wound poses urgent limb-threat risk, request expedited review (72-hour turnaround).
- Step-therapy exception under state law: Many states have enacted step-therapy protection laws requiring insurers to grant exceptions when the step modality is contraindicated or has previously failed. Identify whether the applicable state law applies to Humana's plan type.
- External review (ACA §2719 / ERISA §503): After adverse internal decision, request external review within the ~4-month window.
## Documentation to Gather
1. Prior-offloading history (if step was completed): Dated clinical records showing removable walker/shoe prescription, period of use, and wound-assessment outcome showing failure to heal. 2. Step-therapy exception basis (if bypassing step): Treating provider's letter explaining why the removable step was clinically inappropriate or contraindicated for this specific patient at the time TCC was prescribed. 3. Wound severity documentation: Chart notes documenting wound grade/classification, depth, and clinical characteristics supporting the prescribing decision. 4. Neuropathy and vascular status: Test results confirming the neuropathic etiology and absence of severe ischemia. 5. Prescriber medical-necessity letter: Explaining the clinical decision-making process and the basis for TCC selection at this point in the patient's care.
## Criteria-Mapping Structure
Obtain Humana's wound-care medical coverage policy. Map both the step-therapy criteria and the exception pathway:
| Policy Requirement | Supporting Documentation | |---|---| | Prior removable-offloading trial documented | Dated prescription + visit notes + outcome | | OR: Clinical basis for step-therapy exception | Prescriber letter with specific clinical rationale | | Wound type and grade per policy | Office note with wound-care classification | | Absence of infection/ischemia precluding TCC | Wound culture, ABI/vascular study | | Credentialed applying provider | Credential certificate |
If Humana denies the step-therapy exception, request a written explanation of which specific criterion the exception fails to meet — this focuses the external appeal on a narrow, reviewable question.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →